Koyfin Home > Directory > Health Care > Amgen Inc > Capital Expenditures

Amgen Inc Capital Expenditures Chart (AMGN)

Amgen Inc annual/quarterly Capital Expenditures from 2010 to 2020.
  • Amgen Inc Capital Expenditures for the quarter ending September 09, 2020 was $-135m a -39.26% increase of 53m year over year
  • Amgen Inc Capital Expenditures for the last 12 months ending September 09, 2020 was $-623m a 0.80% decrease of -5m year over year
  • Amgen Inc Annual Capital Expenditures for 2019 was $-618m a -19.42% increase of 120m from 2018
  • Amgen Inc Annual Capital Expenditures for 2018 was $-738m a 10.03% decrease of -74m from 2017
  • Amgen Inc Annual Capital Expenditures for 2017 was $-664m a -11.14% increase of 74m from 2016
Other Cash Flow Metrics:
  • Amgen Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $3,194m a 14.62% increase of 467m year over year
  • Amgen Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $3,068m a 48.86% increase of 1,499m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN Capital Expenditures Data

09/2020$-135m
06/2020$-158m
03/2020$-142m
12/2019$-188m
09/2019$-170m
06/2019$-144m
03/2019$-116m
12/2018$-225m
09/2018$-171m
06/2018$-187m

Annual AMGN Capital Expenditures Data

2019$-618m
2018$-738m
2017$-664m
2016$-738m
2015$-594m
2014$-718m
2013$-693m
2012$-689m
2011$-567m
2010$-580m